Our mission is to be a global leader in generics and biopharmaceuticals, improving the lives of patients across the world.
In a complex world, Teva's mission is simple: to improve the lives of patients across the globe. We believe that everyone should have access to quality medicines whether it be for managing disease, fighting infections, or simply improving overall health.
We are proud that since Teva’s establishment in 1901, healthcare providers together with patients and caregivers have been using our accessible generic and innovative products. Today, our portfolio of around 3,500 products is among the largest of any pharmaceutical company in the world. Nearly 200 million people in 60 countries benefit from one of Teva's quality medicines every day. We invest in research and development of generic medicines and biopharmaceuticals, carrying on the legacy of more than a century of finding new ways to help patients improve their lives. This defines our values as a company and characterizes how we do business and approach medicine.
Teva Canada, headquartered in Toronto, has provided affordable healthcare solutions to Canadians for over 50 years, building trust one prescription at a time with currently more than 220,000 prescriptions filled each day with our products. Originally Novopharm Limited, Teva Canada specializes in the development, production and marketing of high-quality generic prescription pharmaceuticals and through our branded division, focuses on a diverse line of innovative products in a variety of therapeutic areas such as central nervous system (CNS), pain care, respiratory and oncology. Teva Canada employs more than 1,000 professionals and markets more than 385 products in Canada.